Advanced Or Metastatic Solid Tumors clinical trials

Explore recruiting advanced or metastatic solid tumors clinical trials.

Recruiting advanced or metastatic solid tumors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Or Metastatic Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Ireland, Spain, France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD5863, a T cell-engaging Bispecific Antibody that Targets Claudin 18.2 (CLDN18.2) and CD3 in Adult Participants with Advanced or Metastatic Solid Tumors.

Netherlands, France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial

France, Belgium, Poland, Germany, Portugal, Denmark +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2 Study to Evaluate the Safety and Efficacy of Telisotuzumab Adizutecan for the Treatment of Subjects with Locally Advanced or Metastatic Solid Tumors that Harbor MET Amplification

Spain, France, Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

J2G-OX-Y001 - A Multi-Center Expanded Access Program (EAP) for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors with Rearranged During Transfection (RET) Activation (LIBRETTO-201)

Italy, France, Poland, Spain

Therapeutic use (Phase IV) EU CTIS Study details

A Phase I/IIa Open-label Dose Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD7789, an anti-PD-1 and anti-TIM-3 Bispecific Antibody, in Participants with Advanced or Metastatic Solid Tumors

Spain, Netherlands, France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Advanced Or Metastatic Solid Tumors trials by city

Advanced Or Metastatic Solid Tumors in Toronto Advanced Or Metastatic Solid Tumors in Vancouver Advanced Or Metastatic Solid Tumors in Montreal Advanced Or Metastatic Solid Tumors in Calgary Advanced Or Metastatic Solid Tumors in Edmonton Advanced Or Metastatic Solid Tumors in Ottawa Advanced Or Metastatic Solid Tumors in Winnipeg Advanced Or Metastatic Solid Tumors in Quebec City Advanced Or Metastatic Solid Tumors in Hamilton Advanced Or Metastatic Solid Tumors in Kitchener Advanced Or Metastatic Solid Tumors in London Advanced Or Metastatic Solid Tumors in Halifax Advanced Or Metastatic Solid Tumors in New York Advanced Or Metastatic Solid Tumors in Los Angeles Advanced Or Metastatic Solid Tumors in Chicago Advanced Or Metastatic Solid Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease